CEACAM5 and neoplasm: Additionally, it is crucial to treat MMFTC tumors as aggressive variants and monitor patients closely with neck ultrasounds and tumor markers (calcitonin, thyroglobulin, CEA) to detect early signs of recurrence and improve survival.